Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harte Hanks (HHS) Cash from Financing Activities (2016 - 2025)

Harte Hanks has reported Cash from Financing Activities over the past 16 years, most recently at -$41000.0 for Q4 2025.

  • Quarterly Cash from Financing Activities rose 56.38% to -$41000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $514000.0 through Dec 2025, up 222.67% year-over-year, with the annual reading at $514000.0 for FY2025, 222.67% up from the prior year.
  • Cash from Financing Activities was -$41000.0 for Q4 2025 at Harte Hanks, up from -$155000.0 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $4.8 million in Q2 2022 and troughed at -$10.9 million in Q3 2022.
  • The 5-year median for Cash from Financing Activities is -$181000.0 (2021), against an average of -$1.6 million.
  • Year-over-year, Cash from Financing Activities crashed 4205.53% in 2021 and then soared 6084.62% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at -$8.6 million in 2021, then dropped by 9.7% to -$9.4 million in 2022, then soared by 99.09% to -$86000.0 in 2023, then fell by 9.3% to -$94000.0 in 2024, then skyrocketed by 56.38% to -$41000.0 in 2025.
  • Per Business Quant, the three most recent readings for HHS's Cash from Financing Activities are -$41000.0 (Q4 2025), -$155000.0 (Q3 2025), and $778000.0 (Q2 2025).